Is PBS spending set to stall?

Despite headline figures, a peak body says PBS expenditure will slow as a share of GDP - and it could have implications for patients Future investment in the pharmaceutical benefits scheme (PBS) is set to decline as a share of economic growth, despite global headwinds, according to Medicines Australia. Federal Treasurer Dr Jim Chalmers announced